Biocon has entered a partnership with Tabuk Pharmaceuticals for the commercialisation of glucagon-like peptide-1 (GLP-1) ...

The US Food and Drug Administration (FDA) has announced the approval of Sanofi and Regeneron’s interleukin (IL)-4 and IL-13 ...

The FDA has approved the first treatment for schizophrenia that targets cholinergic receptors rather than dopamine receptors.

Pfizer has announced the withdrawal of all lots of OXBRYTA approved for treating sickle cell disease (SCD) from worldwide ...

Opioid use disorder (OUD) is a chronic neurological disorder characterised by the compulsive, repeated use of opioids, ...

Phare Bio has received up to $27m from the Advanced Research Projects Agency for Health (ARPA-H) to advance its drug ...

The US FDA placed a full clinical hold on two diabetes trials for Biomea’s menin inhibitor after reports of liver toxicity.

The collaboration aims to utilise Tempus’ real-world data and biological modelling to enhance the development of Takeda’s ...

Safety processes and regulations apply to custom-made medicines, which differ from traditional pharmacies. Now, however, ...

Takeda has secured the Japanese MHLW approval for its FRUZAQLA to treat unresectable advanced or recurrent colorectal cancer ...

UNICEF has reached an agreement with mpox vaccine manufacturer Bavarian Nordic to supply one million doses of the shot for ...

Orion has entered a partnership with Aitia to leverage artificial intelligence in drug discovery and simulation in the ...